Connect with us
The S&P/ASX200 Index ended Friday’s session with a 1.1 percent increase to cap off an impressive run moving up 5.4 percent for the week. Banks were...
The S&P/ASX200 Index plummeted 2.3 percent on Thursday to cap off a poor month and lost 1.4 percent collectively for Q3. Iron ore miners were a...
The S&P/ASX200 Index jumped 2.4 percent on Wednesday to record its best trading day on two months, fueled by gains from the major banks. Iron ore...
The S&P/ASX200 Index declined 1.2 percent as iron ore large caps and biopharma giant CSL all tumbled on Thursday. Banks grew marginally as Australia and New...
In this final part of a four-part webinar recap, James Graham, Executive Director of Recce Pharmaceuticals (ASX:RCE) presented on the company’s latest announcements and updates, while answering...
In this part three of a four-part webinar recap, Darren Lui, President and Executive Director of Aptorum Group (NASDAQ/EURONEXT:APM) presented on the company’s latest announcements and updates,...
In this part two of a four-part webinar recap, Sean Hall, Chief Executive Officer and Managing Director of Medlab (ASX:MDC) presented on the company’s latest announcements and...
In this one of a four-part webinar recap, Mark Diamond, Managing Director & CEO of Antisense Therapeutics Limited (ASX:ANP) presented on the company’s latest announcements and...
StockPal is hosting its first Biotech & Healthcare webinar on 4 August for four ASX- and NASDAQ-listed health care companies. This webinar is co-organised with Rawson Lewis....
StockPal is hosting its first Biotech & Healthcare webinar for four ASX- and NASDAQ-listed health care companies. Each company is given 15 minutes to present via...